These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15109461

  • 1. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
    Cao JY, Wang H.
    Chin Med J (Engl); 2004 Apr; 117(4):615-7. PubMed ID: 15109461
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P, Bahr J, Wachlin G, Heinke P, Berg S, Salzsieder E, Harrison LC.
    J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
    [Abstract] [Full Text] [Related]

  • 5. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B, Zhang ZL, Yu LY, Guo LH.
    Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
    Augstein P, Heinke P, Salzsieder E, Berg S, Rettig R, Salzsieder C, Harrison LC.
    Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
    [Abstract] [Full Text] [Related]

  • 9. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes.
    Apostolou I, Hao Z, Rajewsky K, von Boehmer H.
    J Exp Med; 2003 Oct 06; 198(7):1103-6. PubMed ID: 14530378
    [Abstract] [Full Text] [Related]

  • 10. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
    Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y.
    Diabetologia; 1999 Nov 06; 42(11):1332-40. PubMed ID: 10550417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ, Zhou ZG, Su H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug 06; 31(4):499-504. PubMed ID: 16951506
    [Abstract] [Full Text] [Related]

  • 13. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY, Chaturvedi P, Singh B.
    Int Immunol; 2004 Dec 06; 16(12):1723-32. PubMed ID: 15492021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Contribution of Fas to diabetes development.
    Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV.
    Proc Natl Acad Sci U S A; 2003 Jan 21; 100(2):628-32. PubMed ID: 12525697
    [Abstract] [Full Text] [Related]

  • 16. [FasL-Fas/APO-1 (CD95) system].
    Sun CK, Ju G.
    Sheng Li Ke Xue Jin Zhan; 1997 Apr 21; 28(2):136-8. PubMed ID: 11038707
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
    Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H, Lee MS.
    J Immunol; 2000 Mar 15; 164(6):2931-6. PubMed ID: 10706679
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.